Abstract

To define the frequency and outcome of organ dysfunction in bone marrow transplantation (BMT) and to determine if patients with organ dysfunction have lower levels of protein C (PC) and/or antithrombin III (ATIII) than those without organ dysfunction. —Inception cohort of patients undergoing BMT, followed for 28 days, until hospital dismissal, or until death. —Bone marrow transplant department of a university hospital. —A total of 199 consecutive patients admitted for BMT. —Standard supportive care was given to all patients. —Definitions of organ dysfunction were arrived at prior to beginning the study. They include pulmonary, central nervous system (CNS), hepatic, and renal dysfunction. Protein C and ATIII levels were measured prior to beginning the preparative regimen and weekly thereafter. —Single organ dysfunction, manifesting as pulmonary, CNS, or hepatic dysfunction, occurred in 93 (48.5%) of the 199 patients and was a strong predictor of multiple organ dysfunction syndrome (MODS) and death. Death occurred in 14 (7.0%) of the patients. Cause of death was precisely identified in only four patients. Low levels of either PC or ATIII were associated with death and pulmonary, CNS, and hepatic dysfunction. Multivariate analysis showed ATIII and PC levels were associated with single organ dysfunction independent of the type of transplant, the type of preparative regimen, and the presence of bacteremia. —Single organ dysfunction during BMT is a marker for a systemic abnormality that has a high likelihood of progressing to MODS, similar to that seen in other critically ill patient populations. MODS is the leading cause of death in series of BMT patients. Low levels of ATIII and PC are markers of and may be involved in the pathogenesis of MODS in BMT.

Original languageEnglish (US)
Pages (from-to)1289-1295
Number of pages7
JournalJAMA: The Journal of the American Medical Association
Volume274
Issue number16
DOIs
StatePublished - Jan 1 1995

Fingerprint

Multiple Organ Failure
Bone Marrow Transplantation
Antithrombin III
Protein C
Antithrombin Proteins
Central Nervous System
Lung
Cause of Death
Liver
Transplants
Bacteremia
Critical Illness
Multivariate Analysis
Bone Marrow
Kidney

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation. / Stephens, Lana C.; Kotulak, Gail D.; Reed, Elizabeth Cecile; Vose, Julie Marie; Bierman, Philip Jay; Kessinger, Margaret Anne; Armitage, James Olen; Haire, William D.; Gordon, Bruce Geoffrey; Ruby, Elizabeth I.; Patil, Kashinath D.

In: JAMA: The Journal of the American Medical Association, Vol. 274, No. 16, 01.01.1995, p. 1289-1295.

Research output: Contribution to journalArticle

Stephens, Lana C. ; Kotulak, Gail D. ; Reed, Elizabeth Cecile ; Vose, Julie Marie ; Bierman, Philip Jay ; Kessinger, Margaret Anne ; Armitage, James Olen ; Haire, William D. ; Gordon, Bruce Geoffrey ; Ruby, Elizabeth I. ; Patil, Kashinath D. / Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation. In: JAMA: The Journal of the American Medical Association. 1995 ; Vol. 274, No. 16. pp. 1289-1295.
@article{a56685bfdf6a4292939b3d46c80b8171,
title = "Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation",
abstract = "To define the frequency and outcome of organ dysfunction in bone marrow transplantation (BMT) and to determine if patients with organ dysfunction have lower levels of protein C (PC) and/or antithrombin III (ATIII) than those without organ dysfunction. —Inception cohort of patients undergoing BMT, followed for 28 days, until hospital dismissal, or until death. —Bone marrow transplant department of a university hospital. —A total of 199 consecutive patients admitted for BMT. —Standard supportive care was given to all patients. —Definitions of organ dysfunction were arrived at prior to beginning the study. They include pulmonary, central nervous system (CNS), hepatic, and renal dysfunction. Protein C and ATIII levels were measured prior to beginning the preparative regimen and weekly thereafter. —Single organ dysfunction, manifesting as pulmonary, CNS, or hepatic dysfunction, occurred in 93 (48.5{\%}) of the 199 patients and was a strong predictor of multiple organ dysfunction syndrome (MODS) and death. Death occurred in 14 (7.0{\%}) of the patients. Cause of death was precisely identified in only four patients. Low levels of either PC or ATIII were associated with death and pulmonary, CNS, and hepatic dysfunction. Multivariate analysis showed ATIII and PC levels were associated with single organ dysfunction independent of the type of transplant, the type of preparative regimen, and the presence of bacteremia. —Single organ dysfunction during BMT is a marker for a systemic abnormality that has a high likelihood of progressing to MODS, similar to that seen in other critically ill patient populations. MODS is the leading cause of death in series of BMT patients. Low levels of ATIII and PC are markers of and may be involved in the pathogenesis of MODS in BMT.",
author = "Stephens, {Lana C.} and Kotulak, {Gail D.} and Reed, {Elizabeth Cecile} and Vose, {Julie Marie} and Bierman, {Philip Jay} and Kessinger, {Margaret Anne} and Armitage, {James Olen} and Haire, {William D.} and Gordon, {Bruce Geoffrey} and Ruby, {Elizabeth I.} and Patil, {Kashinath D.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1001/jama.1995.03530160041031",
language = "English (US)",
volume = "274",
pages = "1289--1295",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "16",

}

TY - JOUR

T1 - Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation

AU - Stephens, Lana C.

AU - Kotulak, Gail D.

AU - Reed, Elizabeth Cecile

AU - Vose, Julie Marie

AU - Bierman, Philip Jay

AU - Kessinger, Margaret Anne

AU - Armitage, James Olen

AU - Haire, William D.

AU - Gordon, Bruce Geoffrey

AU - Ruby, Elizabeth I.

AU - Patil, Kashinath D.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - To define the frequency and outcome of organ dysfunction in bone marrow transplantation (BMT) and to determine if patients with organ dysfunction have lower levels of protein C (PC) and/or antithrombin III (ATIII) than those without organ dysfunction. —Inception cohort of patients undergoing BMT, followed for 28 days, until hospital dismissal, or until death. —Bone marrow transplant department of a university hospital. —A total of 199 consecutive patients admitted for BMT. —Standard supportive care was given to all patients. —Definitions of organ dysfunction were arrived at prior to beginning the study. They include pulmonary, central nervous system (CNS), hepatic, and renal dysfunction. Protein C and ATIII levels were measured prior to beginning the preparative regimen and weekly thereafter. —Single organ dysfunction, manifesting as pulmonary, CNS, or hepatic dysfunction, occurred in 93 (48.5%) of the 199 patients and was a strong predictor of multiple organ dysfunction syndrome (MODS) and death. Death occurred in 14 (7.0%) of the patients. Cause of death was precisely identified in only four patients. Low levels of either PC or ATIII were associated with death and pulmonary, CNS, and hepatic dysfunction. Multivariate analysis showed ATIII and PC levels were associated with single organ dysfunction independent of the type of transplant, the type of preparative regimen, and the presence of bacteremia. —Single organ dysfunction during BMT is a marker for a systemic abnormality that has a high likelihood of progressing to MODS, similar to that seen in other critically ill patient populations. MODS is the leading cause of death in series of BMT patients. Low levels of ATIII and PC are markers of and may be involved in the pathogenesis of MODS in BMT.

AB - To define the frequency and outcome of organ dysfunction in bone marrow transplantation (BMT) and to determine if patients with organ dysfunction have lower levels of protein C (PC) and/or antithrombin III (ATIII) than those without organ dysfunction. —Inception cohort of patients undergoing BMT, followed for 28 days, until hospital dismissal, or until death. —Bone marrow transplant department of a university hospital. —A total of 199 consecutive patients admitted for BMT. —Standard supportive care was given to all patients. —Definitions of organ dysfunction were arrived at prior to beginning the study. They include pulmonary, central nervous system (CNS), hepatic, and renal dysfunction. Protein C and ATIII levels were measured prior to beginning the preparative regimen and weekly thereafter. —Single organ dysfunction, manifesting as pulmonary, CNS, or hepatic dysfunction, occurred in 93 (48.5%) of the 199 patients and was a strong predictor of multiple organ dysfunction syndrome (MODS) and death. Death occurred in 14 (7.0%) of the patients. Cause of death was precisely identified in only four patients. Low levels of either PC or ATIII were associated with death and pulmonary, CNS, and hepatic dysfunction. Multivariate analysis showed ATIII and PC levels were associated with single organ dysfunction independent of the type of transplant, the type of preparative regimen, and the presence of bacteremia. —Single organ dysfunction during BMT is a marker for a systemic abnormality that has a high likelihood of progressing to MODS, similar to that seen in other critically ill patient populations. MODS is the leading cause of death in series of BMT patients. Low levels of ATIII and PC are markers of and may be involved in the pathogenesis of MODS in BMT.

UR - http://www.scopus.com/inward/record.url?scp=0028840297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028840297&partnerID=8YFLogxK

U2 - 10.1001/jama.1995.03530160041031

DO - 10.1001/jama.1995.03530160041031

M3 - Article

VL - 274

SP - 1289

EP - 1295

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 16

ER -